This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wellinghausen, N.
Right arrow Articles by Poppert, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wellinghausen, N.
Right arrow Articles by Poppert, S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2005, p. 4070-4075, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4070-4075.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Superiority of Molecular Techniques for Identification of Gram-Negative, Oxidase-Positive Rods, Including Morphologically Nontypical Pseudomonas aeruginosa, from Patients with Cystic Fibrosis

Nele Wellinghausen,* Juliane Köthe, Beate Wirths, Anja Sigge, and Sven Poppert

Department of Medical Microbiology and Hygiene, University of Ulm, Ulm, Germany

Received 3 February 2005/ Returned for modification 16 March 2005/ Accepted 29 April 2005

Phenotypic identification of gram-negative bacteria from Cystic Fibrosis (CF) patients carries a high risk of misidentification. Therefore, we compared the results of biochemical identification by API 20NE with 16S rRNA gene sequencing in 88 gram-negative, oxidase-positive rods, other than morphologically and biochemically typical P. aeruginosa, from respiratory secretions of CF patients. The API 20NE allowed correct identification of the bacterial species in 15 out of 88 (17%) isolates investigated. Agreement between the API and the 16S rRNA gene sequencing results was high only in isolates with an API result classified as "excellent identification." Even API results classified as "very good identification" or "good identification" showed a high rate of misidentification (67% and 84%). Fifty-two isolates of morphological and biochemical nontypical Pseudomonas aeruginosa, representing 59% of all isolates investigated, were not identifiable or misidentified in the API 20NE. Therefore, rapid molecular diagnostic techniques like real-time PCR and fluorescence in situ hybridization (FISH) were evaluated in this particular group of bacteria for identification of the clinically most relevant pathogen, P. aeruginosa. The LightCycler PCR assay with a P. aeruginosa-specific probe showed a sensitivity and specificity of 98.1% and 100%, respectively. For FISH analysis, a newly designed P. aeruginosa-specific probe had a sensitivity and specificity of 100%. In conclusion, molecular methods are superior over biochemical tests for identification of gram-negative, oxidase-positive rods in CF patients. In addition, real-time PCR and FISH allowed identification of morphologically nontypical isolates of P. aeruginosa within a few hours.


* Corresponding author. Mailing address: Department of Medical Microbiology and Hygiene, University of Ulm, Robert-Koch-Str. 8, D-89081 Ulm, Germany. Phone: 49-(0)731-500 24602. Fax: 49-(0)731-500 23473. E-mail: nele.wellinghausen{at}medizin.uni-ulm.de.


Journal of Clinical Microbiology, August 2005, p. 4070-4075, Vol. 43, No. 8
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.8.4070-4075.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Kidd, T. J., Ramsay, K. A., Hu, H., Bye, P. T. P., Elkins, M. R., Grimwood, K., Harbour, C., Marks, G. B., Nissen, M. D., Robinson, P. J., Rose, B. R., Sloots, T. P., Wainwright, C. E., Bell, S. C., and the ACPinCF Investigators, (2009). Low Rates of Pseudomonas aeruginosa Misidentification in Isolates from Cystic Fibrosis Patients. J. Clin. Microbiol. 47: 1503-1509 [Abstract] [Full Text]  
  • Foweraker, J. (2009). Recent advances in the microbiology of respiratory tract infection in cystic fibrosis. Br Med Bull 89: 93-110 [Abstract] [Full Text]  
  • Degand, N., Carbonnelle, E., Dauphin, B., Beretti, J.-L., Le Bourgeois, M., Sermet-Gaudelus, I., Segonds, C., Berche, P., Nassif, X., Ferroni, A. (2008). Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Nonfermenting Gram-Negative Bacilli Isolated from Cystic Fibrosis Patients. J. Clin. Microbiol. 46: 3361-3367 [Abstract] [Full Text]  
  • Wellinghausen, N., Wirths, B., Poppert, S. (2006). Fluorescence In Situ Hybridization for Rapid Identification of Achromobacter xylosoxidans and Alcaligenes faecalis Recovered from Cystic Fibrosis Patients.. J. Clin. Microbiol. 44: 3415-3417 [Abstract] [Full Text]  
  • Bosshard, P. P., Zbinden, R., Abels, S., Boddinghaus, B., Altwegg, M., Bottger, E. C. (2006). 16S rRNA Gene Sequencing versus the API 20 NE System and the VITEK 2 ID-GNB Card for Identification of Nonfermenting Gram-Negative Bacteria in the Clinical Laboratory. J. Clin. Microbiol. 44: 1359-1366 [Abstract] [Full Text]